LOUIS CUBBA: Open Payments
NPI 1649201716 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$58,313 in 80 payments from 3 companies in 2025. Trend: 2023 $58,161 · 2024 $71,780 · 2025 $58,313
Speaker / faculty: $45,375Travel & lodging: $7,027Consulting: $3,935Food & beverage: $1,976
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 48 | $33,687 |
| Gilead Sciences, Inc. | 31 | $23,651 |
| Shionogi Inc | 1 | $975 |
Products named: RUKOBIA, Biktarvy, APRETUDE, Descovy, Yeztugo, S-217622, CABENUVA, DOVATO.
Industry payments across CA — which companies pay providers there.
